首页> 外文期刊>Science >AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
【24h】

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

机译:AIB1,一种在乳腺癌和卵巢癌中扩增的类固醇受体共激活因子

获取原文
获取原文并翻译 | 示例
       

摘要

Members of the recently recognized SRC-1 family of transcriptional coactivators interact with steroid hormone receptors to enhance ligand-dependent transcription. AIB1, a member of the SRC-1 family, was cloned during a search on the long arm of chromosome 20 for genes whose expression and copy number were elevated in human breast cancers. AIB1 amplification and overexpression were observed in four of five estrogen receptor-positive breast and ovarian cancer cell lines. Subsequent evaluation of 105 unselected specimens of primary breast cancer found AIB1 amplification in approximately 10 percent and high expression in 64 percent of the primary tumors analyzed. AIB1 protein interacted with estrogen receptors in a ligand-dependent fashion, and transfection of AIB1 resulted in enhancement of estrogen-dependent transcription. These observations identify AIB1 as a nuclear receptor coactivator whose altered expression may contribute to development of steroid-dependent cancers.
机译:最近公认的SRC-1转录共激活因子家族成员与类固醇激素受体相互作用,以增强配体依赖性转录。 SIB-1家族的成员AIB1是在20号染色体的长臂上搜索人类乳腺癌中表达和拷贝数升高的基因时克隆的。在五个雌激素受体阳性乳腺癌和卵巢癌细胞系中的四个中观察到了AIB1扩增和过表达。随后对105例未经选择的原发性乳腺癌标本进行的评估发现,在所分析的原发性肿瘤中,AIB1扩增约占10%,高表达占64%。 AIB1蛋白以配体依赖性的方式与雌激素受体相互作用,而AIB1的转染导致雌激素依赖性转录的增强。这些观察结果表明,AIB1是一种核受体共激活因子,其表达改变可能有助于类固醇依赖型癌症的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号